Our Strategic Vision
DFCR utilizes a three-pronged effort to advance our mission, focusing on Advocacy, Education, and Regulation.
Core to our advocacy efforts, DFCR is proactive in guiding the narrative of cannabis legalization, providing commentary on regulations early in the electoral, legislative, and regulatory process. These efforts include the researching and tracking of ballot and legislative initiatives around the country. Consistent with our role as medical professionals, our efforts focus on offering science-based regulatory recommendations to support public health.
DFCR works with medical professionals to expand the endorsement for legalization and regulation by medical organizations, with a focus on correcting long-standing misconceptions about the harms of cannabis to the individual and to public health.
DFCR develops partnerships with other organizations committed to cannabis legalization and regulation. These partnerships demonstrate our shared vision, collaboration, and mutual support with other non-profit organizations. By working in collaboration with our Partners, we can multiply the effects of our individual efforts. In addition, we can ensure that the unique voices of physicians and other medical professionals are part of the conversation.
DFCR also develops partnerships with physicians, other medical professionals, and medical organizations in non-U.S. countries to encourage the legalization and regulation of cannabis worldwide.
Education is the backbone of our advocacy efforts. Our primary campaigns focus on expounding three underlying messages:
- The war on cannabis is detrimental to public health.
- Cannabis regulation benefits public health.
- Many of the fears of cannabis legalization are unfounded.
DFCR provides specific guidance to federal and regional lawmakers, voters, and medical organizations on the optimal approaches for cannabis regulation. These efforts include:
- Recommendations directly relevant to our expertise as medical professionals.
- The development of a universal symbol to inform the public that a product contains cannabinoids (an International Intoxicating Cannabis Product Symbol, or IICPS).